Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
Revenue
Pacific Biosciences of California Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Revenue
$200.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
21%
|
CAGR 10-Years
22%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Pacific Biosciences of California Inc's Revenue?
Revenue
200.5m
USD
Based on the financial report for Dec 31, 2023, Pacific Biosciences of California Inc's Revenue amounts to 200.5m USD.
What is Pacific Biosciences of California Inc's Revenue growth rate?
Revenue CAGR 10Y
22%
Over the last year, the Revenue growth was 56%. The average annual Revenue growth rates for Pacific Biosciences of California Inc have been 36% over the past three years , 21% over the past five years , and 22% over the past ten years .